Skip to main content
Premium Trial:

Request an Annual Quote

IDT Signs qPCR Probe Licensing Deal with EliTech

NEW YORK (GenomeWeb) – Integrated DNA Technologies said today it has obtained a license to manufacture and supply EliTech Group's MGB Eclipse qPCR probes for use in human in vitro diagnostic tests.

In a statement, Roman Terrill, general counsel and GMP business unit leader for IDT, said, "MGB Eclipse Probes complement our existing GMP qPCR product portfolio and provide our customers with more choice for probe selection." He noted that many of the firm's customers have already developed qPCR-based diagnostic tests using MGB Eclipse Probes labeled for research use only and that today's deal allows IDT to offer GMP-manufactured probes for laboratory developed tests and other diagnostics products.

MGB Eclipse Probes are comprised of oligonucleotides coupled to fluorescent dyes, Elcipse Dark Quenchers, and minor groove binders. The probes are licensed to Coralville, Iowa-based IDT for use solely in human in vitro diagnostic end-use applications, IDT said.

EliTech, based in Puteaux, France, manufactures and develops in vitro diagnostic equipment and reagents. IDT manufactures custom, synthetic DNA and RNA oligonucleotides for use in biotechnology, clinical diagnostics, and pharmaceutical development.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.